Presentation is loading. Please wait.

Presentation is loading. Please wait.

Wayne L. Miller et al. JCHF 2013;1:

Published byUtami Agusalim Modified over 5 years ago

Similar presentations

Presentation on theme: "Wayne L. Miller et al. JCHF 2013;1:"— Presentation transcript:

1 Wayne L. Miller et al. JCHF 2013;1:290-299
Survival of HFREF Patients With PH (A) Kaplan-Meier estimates of survival in patients with heart failure of reduced left ventricular ejection fraction (HFREF) relative to passive pulmonary hypertension (PH) and mixed PH as defined by pulmonary vascular resistance (PVR) < or ≥3.0 Wood units (WU) and no PH. (B) Kaplan-Meier estimates of survival in patients with HFREF relative to passive PH and mixed PH as defined by transpulmonary gradient (TPG) < and ≥12 mm Hg and no PH. Wayne L. Miller et al. JCHF 2013;1: 2013 American College of Cardiology Foundation

Download ppt "Wayne L. Miller et al. JCHF 2013;1:"

Similar presentations

Picture of my family – love to start talks in the comfort of my living room. Feel passionate about my girls and about this unique population of patients.

Picture of my family – love to start talks in the comfort of my living room. Feel passionate about my girls and about this unique population of patients.
From: Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure: A Systematic Overview and Meta-Analysis.

From: Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure: A Systematic Overview and Meta-Analysis.
From: Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction.

From: Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction.
Hemodynamic classification of pulmonary hypertension (PH)

Hemodynamic classification of pulmonary hypertension (PH)
Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),

Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),
Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.

Echocardiographic modalities for evaluation and risk stratification of heart failure patients. 3D indicates 3-dimensional; EF, ejection fraction; LA, left.
Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.
Left Ventricular Dysfunction With Pulmonary Hypertension

Left Ventricular Dysfunction With Pulmonary Hypertension
Noriko Kikuchi et al. JACEP 2016;2:

Noriko Kikuchi et al. JACEP 2016;2:
Patrizio Lancellotti et al. JIMG 2016;9:

Patrizio Lancellotti et al. JIMG 2016;9:
Exercise-Induced Pulmonary Hypertension

Exercise-Induced Pulmonary Hypertension
Shadi Al Halabi et al. JACEP 2015;1:

Shadi Al Halabi et al. JACEP 2015;1:
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
G. Michael Felker et al. JCHF 2014;2:

G. Michael Felker et al. JCHF 2014;2:
Carolyn Y. Ho et al. JCHF 2015;3:

Carolyn Y. Ho et al. JCHF 2015;3:
Alan G. Japp et al. JACC 2016;67:2996-3010 Differentiation of Athlete’s Heart From Early DCM by Myocardial Deformation Imaging Two-dimensional speckle.

Alan G. Japp et al. JACC 2016;67: Differentiation of Athlete’s Heart From Early DCM by Myocardial Deformation Imaging Two-dimensional speckle.
Johannes Steiner et al. JACC 2017;70:

Johannes Steiner et al. JACC 2017;70:
Johannes Steiner et al. JACC 2017;70:

Johannes Steiner et al. JACC 2017;70:
Caroline Zotter-Tufaro et al. JCHF 2015;3:

Caroline Zotter-Tufaro et al. JCHF 2015;3:
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Similar presentations

Ads by Google